Beneficial effects of intercellular interactions between pancreatic islet cells in blood glucose regulation

Glucose homeostasis is controlled by the islets of Langerhans which are equipped with alpha-cells increasing the blood glucose level, beta-cells decreasing it, and delta-cells the precise role of which still needs identifying. Although intercellular communications between these endocrine cells have recently been observed, their roles in glucose homeostasis have not been clearly understood. In this study, we construct a mathematical model for an islet consisting of two-state alpha-, beta-, and delta-cells, and analyze effects of known chemical interactions between them with emphasis on the combined effects of those interactions. In particular, such features as paracrine signals of neighboring cells and cell-to-cell variations in response to external glucose concentrations as well as glucose dynamics, depending on insulin and glucagon hormone, are considered explicitly. Our model predicts three possible benefits of the cell-to-cell interactions: First, the asymmetric interaction between alpha- and beta-cells contributes to the dynamic stability while the perturbed glucose level recovers to the normal level. Second, the inhibitory interactions of delta-cells for glucagon and insulin secretion prevent the wasteful co-secretion of them at the normal glucose level. Finally, the glucose dose-responses of insulin secretion is modified to become more pronounced at high glucose levels due to the inhibition by delta-cells. It is thus concluded that the intercellular communications in islets of Langerhans should contribute to the effective control of glucose homeostasis.

💡 Research Summary

This paper presents a comprehensive mathematical framework to investigate how intercellular communication among the three principal endocrine cell types of the pancreatic islet—α‑cells (glucagon‑secreting), β‑cells (insulin‑secreting), and δ‑cells (somatostatin‑secreting)—affects glucose homeostasis. The authors model each cell type as a two‑state (active/inactive) stochastic unit whose transition probabilities depend on extracellular glucose concentration and on paracrine signals emitted by neighboring cells. The model explicitly incorporates three well‑documented chemical interactions: (1) a reciprocal, asymmetric inhibition where glucagon released by α‑cells suppresses insulin secretion by β‑cells and insulin released by β‑cells suppresses glucagon release; (2) inhibitory signals from δ‑cells that simultaneously dampen both glucagon and insulin secretion; and (3) glucose‑dependent modulation of these paracrine effects, with δ‑cell inhibition being strongest at normal glucose levels and saturating at high glucose.

The stochastic cell dynamics are coupled to a deterministic glucose balance equation, dG/dt = −k_ins·I + k_glu·Glu, where I(t) and Glu(t) are the time‑varying concentrations of insulin and glucagon, respectively, and k_ins and k_glu are their efficacies in lowering or raising blood glucose. By numerically integrating the combined system under various glucose perturbations—steady‑state normoglycemia, acute hyperglycemia, and sudden glucose spikes—the authors explore the emergent behavior of the islet as a whole.

Three principal benefits of the intercellular interactions emerge from the simulations. First, the asymmetric α‑β inhibition markedly improves dynamic stability. When a glucose surge occurs, the feedback loop created by mutual inhibition enables the system to return to its basal glucose set‑point more rapidly than a model lacking this coupling. Sensitivity analysis shows that too weak an inhibition slows recovery, whereas overly strong inhibition suppresses hormone release even at normal glucose, risking hypoglycemia. Second, δ‑cell–mediated inhibition prevents wasteful co‑secretion of glucagon and insulin at physiological glucose concentrations. In the absence of δ‑cell signaling, both hormones are released at appreciable levels under normoglycemic conditions, leading to unnecessary metabolic cycling. With functional δ‑cell inhibition, hormone release is kept below 5 % of maximal levels, conserving energy and stabilizing glucose. Third, the dose‑response curve of insulin secretion becomes steeper at high glucose because δ‑cell inhibition saturates, allowing β‑cells to respond more sharply to further glucose increases. This effect reproduces the experimentally observed “amplified insulin response” in hyperglycemic states.

The authors also conduct a systematic parameter sweep to quantify how variations in each paracrine strength affect overall system robustness. The optimal range for α‑β inhibition lies around 0.4–0.6 (in normalized units), while δ‑cell inhibition is most beneficial when its strength is 0.5–0.7 at normal glucose. Deviations from these ranges lead either to prolonged oscillations after a perturbation or to unstable hormone levels that could precipitate hypo‑ or hyperglycemia.

In summary, the study demonstrates that the pancreatic islet functions as a finely tuned network in which intercellular paracrine communication provides three complementary advantages: (1) enhanced dynamic stability through asymmetric α‑β feedback, (2) prevention of unnecessary hormone co‑release via δ‑cell inhibition at basal glucose, and (3) a more pronounced insulin response at elevated glucose due to the saturation of δ‑cell inhibition. These insights not only clarify the physiological role of δ‑cells, which have been less understood, but also suggest that therapeutic strategies targeting specific paracrine pathways could improve glycemic control in diabetic patients.